Abstract
Introduction
The Ocular Cicatricial Pemphigoid (OCP) is an immune-mediated chronic inflammatory disease of the eye, characterized by chronic-recurrent conjunctival inflammation, progressive subepithelial fibrosis and tissue remodeling [1] [2] [3] . Inflammatory infiltrates and activated Fibroblasts (FBs) contribute actively to the uncontrolled extracellular matrix (ECM) deposition (remodeling process), leading to structural and functional changes (keratinization and blindness) [3, 4] . Several pro-inflammatory/fibrogenic cytokines and growth factors, including Transforming Growth Factor β1 (TGFβ1) and Interleukin 4 (IL4), have shown the ability to modulate the survival of activated FBs and their collagen deposition [2, [5] [6] [7] .
An involvement of Nerve Growth Factor (NGF) pathway in OCP has been previously reported by our group: an increased trkA NGFR immunoreactivity has been observed in OCP conjunctival stroma and a consistent NGF release has been quantified in OCP tears [8, 9] . The effect of NGF in tissue remodelling and fibroblast activity is actually controversial: NGF might exert pro/anti-inflammatory effects or profibrogenic activity, acting as a "modulator" of the local immune/inflammatory response, in a receptor expression dependent manner [10] [11] [12] [13] [14] [15] [16] . In the last decade, the NGF modulatory effect on Fibroblasts (FBs) and their activated myofibroblast counterpart (myoFBs) has been prospected in view of the surface trkA NGFR /p75 NTR rate expression and the NGF ability to trigger apoptosis in FBs from different tissues as well as TGFβ1-induced myoFBs [17] [18] [19] [20] [21] .
To address the question as whether NGF might modulate OCP-fibrosis, activated FBs and NGF immunoreactivity were verified both in tissues and cultures. Next, the study was extended to the in vitro characterization of OCP-FBs and the potential NGF influence on OCP-FB phenotype by monitoring αSMA, trkA NGFR /p75 NTR and TGFβ1/IL4 in NGF-exposed OCP subcultures.
Materials and Methods

Ethics Statement
The study followed the guidelines of the Declaration of Helsinki for research involving human subjects and was approved by the intramural Ethical committee (UCBM). Informed written consent was signed by each patient adhering to the study.
Patients and conjunctival specimens
Conjunctival biopsies were obtained from 7 patients with clinical and histological (Hematoxylin & Eosin, HE; Bio-Optica, Milan, Italy) diagnosis of OCP (2M/5F; mean age, SD, range 55-88 years) and from 6 healthy age matched patients (control group), during routine cataract surgery (5M/1F; mean age, SD, range 59-81 years). Two fragments were produced from each biopsy: one conjunctival fragment was included in paraffin and sectioned to provide 5μm-sections for light/confocal microscopy, while the other fragment was used to achieve primary culture of conjunctival OCP FBs.
OCP specimens were classified according to the stage of the disease [22, 23] and grouped as follows: early group comprising 3 patients (stages I or II; Foster) and advanced group including 4 patients (stages III or IV). The immunofluorescent analysis was performed for identifying the presence of a linear immunoglobulin deposition alongside the Basament Membrane Zone (BMZ), according to the specific immunoreactivity (FC-coupled IgGAM antibodies; OBT0119F; Oxford Biotech., Oxford, UK), univocally present in OCP positive sections. Basal histology included Giemsa (48900; Fluka, Milan, Italy), Haematoxylin and Eosin (HE; 05-M06014/ 05-M10002;Bio-Optica; Milan, Italy) as well as the Periodic Acid Schiff (PAS; 04-130802/ 05-M06002; Bio-Optica; Milan, Italy) stainings.
All sterile tissue culture plastic-ware and reagents were from NUNC (Roskilde, Denmark) and Serva (Heidelberg, Germany). Culture media and supplements were from Euroclone (Milan, Italy). Ultrapure/RNAse free water was provided by Direct-Q5 Apparatus (Millipore, Vimodrone, Milan, Italy).
Explants, FB subcultures and NGF studies
Conjunctival fragments were put as explants in 24-well plates and left to attach for 10min before adding DMEM supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS), 1mM sodium Pyruvate, 2mM glutamine, 100U/mL penicillin and 100μg/mL streptomycin (37°C, 5% CO 2 in air) [17, 18] . Outgrowing FBs were quickly harvested (0.2% trypsin-0.025% EDTA; HyQ trypsin; HyClone, Waltham, MA) and directly used or sub-cultured in T-21cm 2 / T-75cm 2 flasks (3 rd -5 th passage) for NGF exposure. The cell culture purity was estimated by the CK19 exclusion test (anti-cytokeratin 19 conjunctival epithelial marker, 1/100; Dako, Hamburg, Germany). For stimulation studies, serum starved confluent monolayers were exposed to increasing NGF concentrations (0 to 100ng/mL β-NGF Grade I; Alomone Labs Ltd, Jerusalem, Israel) or 1ng/mL TGFβ1 (positive control; R&D system, Minneapolis, MN) performed in 0.5% FBS-DMEM for 24hrs.
Conditioned media were collected for ELISA/Western Blot analysis, while monolayers were directly processed for confocal analysis or treated with trypsin-EDTA solution to obtain single cells for molecular (10 5 cells) / biochemical (10 6 cells) analysis.
Confocal Analysis
Conjunctival sections and monolayers were subjected to fluorescent immunostaining. Cruz, CA). The specific binding was detected by using Cy2/Cy3-conjugated specie-specific secondary antibodies, depending on the specific staining (1/500-1/700; Jackson ImmunoResearch Labs., Europe Ltd, Suffolk, UK). Nuclei were counterstained with Propidium Iodide (5μg/mL; ICN, Milan, Italy). Acquisitions were carried out using the E2000U confocal microscope equipped with C1 software (Nikon, Tokyo, Japan). Control sections were stained in parallel (control irrelevant IgGs; Vector Laboratories, Inc. Burlingame, CA) and used for the channelseries acquisitions (Nikon). Relative Real-Time PCR analysis
Flow cytometry
Total RNA was extracted from confluent monolayers using the Puregene RNA purification kit (Gentra Systems, Minnesota, USA). Total RNA samples were spectrophotometrically analysed (ND-1000; NanoDrop, Wilmington, DE; λ 260 /λ 280 >1.8). Total RNA (3 μg) samples were reverse transcribed to a final volume of 21μlL, using 50 pM oligo dT21-primer, 1 mM dNTP mix and 200 U reverse transcriptase (IMPROM; Promega, Milan, Italy) in a programmable PTC100 thermocycler (MJ Research, Watertown, MA) and 3μL were run for amplification with the specific target/referring primers in an Opticon2 MJ thermocycler (MJ Research), according to the manufacturers' instructions (Table 1) . PCR experiments were carried out in a final volume of 20μL containing 3μL cDNA for target genes (or 1μL/3μL for GAPDH/H3 reference genes) and 17μL of master mix [10μL SYBR Green PCR Mix (Applied Biosystems, Foster City, CA), 0.5μL of each primer (10 pM; MWG, Biotech, Ebersberg, Germany) and milliQ-water]. Amplicons were verified for their specificity according to the Southern blotting analysis. Negative controls (without template or with total RNA) were carried out for each run, to rule out any genome contamination. Single threshold cycle values (Cts) were run in the REST 384-2006 software [24] to get increase or decrease difference in target gene expression, with respect to reference genes and compared to controls. Data are gene expression ratio provided in log2 scale.
ELISA
To evaluate NGF in the culture media, a two site NGF-ELISA (0.5pg/mL sensitivity and no cross-reactivity) was carried out in Maxisorp NUNC 96 well ELISA plates precoated with mouse anti-NGF antibodies (0.4μg/mL; MAB256, R&D) and incubated with standards (0.15pg/mL to 1ng/mL β-NGF; Alomone) or prediluted samples (1:3). The following steps included as follows: the biotinylated polyclonal anti-NGF antibodies (0.15μg/mL; BAF256, R&D), the streptavidin solution (Biosource International, Camarillo, CA) and the TMB substrate (Biosource). Optical density was detected by an ELISA plate reader (λ 450-550 ; Sunrise; Tecan Systems, Inc., San Jose, CA) and calculations were carried out according to the protein normalization (A280 Nanodrop) [16] . The biological activity of NGF released by OCP-FBs was verified separately by using a PC12 bioassay (see [18] ). TGFβ1 and IL4 were measured in the conditioned media by commercially available ELISA kits, according to the manufacturers' instructions (Biosource).
Western Blotting
Total proteins were extracted from single-cells lysed in modified RIPA buffer [50 mM TrisHCl (pH 7.7), 150mM NaCl, 1%Triton X-100 and 0.1% SDS] freshly supplemented with phosphatase/protease inhibitors (Pierce). Equivalent amounts of protein (30μg) were subjected to 7-15% SDS-PAGE electrophoresis (Miniprotean3; Bio-Rad, Hercules, CA) and resolved proteins were transferred to Hy-bond membranes (semi-dry blotting apparatus; Bio-Rad). The membranes were washed in 0.05% Tween 20 in PBS (TW-PBS), blocked in 5% non-fat dry milk-PBS and probed with trkA NGFR (1/700), p75 NTR (1/500), αSMA (1/500) and GAPDH (1/ 1000) primary antibodies, followed by secondary POD-conjugated specie-specific antibodies (1/10000; Jackson Immuneresearch). Developing was performed according to the ECL technique (SuperSignal West Pico Trial; Pierce, Rockford, IL). Bands were acquired/analysed in a Kodak Image station equipped with a 1D Image analysis software (110F; Kodak, Tokyo, Japan).
Statistical Analysis
All experimental procedures were conducted in triplicate, each one repeated three times. Both molecular and biochemical data (means±SD) were analysed for significant differences (p < .05), by the ANOVA-Tukey-Kramer coupled post-hoc analysis (StatView II for PC; Abacus Concepts. Inc., Barkley, CA). REST-ANOVA analysis followed by Tukey Kramer posthoc comparisons was used to validate molecular data.
Results
Only conjunctival biopsies from patients' with confirmed ophthalmic and microscopic diagnosis of OCP were included in this study. Immunofluorescent staining revealed the presence of a clear linear fluorescence alongside the BMZ, representative of autoantibodies deposition in both early (A) and advanced (B) OCP sections (Fig 1) . No significant difference in IgGAM immunoreactivity was observed between early and advanced OCP, except for an increasing fluorescent signal in the epithelium and stroma (asterisk; Fig 1B) . Contiguous to those IgGAM staining, basal histology was also performed by using Giemsa (Fig 1C and 1D) , HE ( Fig 1E and The amplification program was as follows: 95°C/15min, followed by 47 cycles of denaturation at 94°C/15sec, annealing Ta* at 25sec or 30sec, extension at 72°C/15sec. Melting curves for each specific primer were monitored between 60°C-90°C, at the end of amplification, before a further extension at 75°C/5min. In bold, referring gene details; *Ta, annealing temperature; bp, base-pairs of amplicons.
doi:10.1371/journal.pone.0142737.t001
1F) and PAS (Fig 1G and 1H) . A depletion of goblet cells was observed in early OCP (arrowheads) while the absence of goblet cells was detected in advanced OCP, as pointed in Giemsa, HE and particularly PAS panels (Fig 1C-1H) . The presence of squamous metaplasia (pluristratified non-keratinised epithelial with absence of goblet cells and homogenization of connective tissue) was particularly evident in advanced OCP (see § in Fig 1D and 1F) . A marked vessel ectasia was particularly evident in early OCP (see asteriks in Fig 1E) . Edema and mild infiltrates with prevalence of plasmacells (arrows) were observed in early with respect to advanced OCP (Fig 1C) .
Characterization of activated FBs
Adjacent conjunctival sections and primary cultures of FBs were analysed for αSMA expression by confocal microscopy and flow cytometry (FCM) analysis. As shown in Fig 2, αSMA immunoreactivity in outgrowth of OCP-tissue (B) and outgrew FBs (D), as compared to control specimens (respectively A and C; p < .05). FCM analysis confirmed the higher αSMA protein expression in OCP-FBs (Fig 2E; observed by confocal analysis, NGF expression was decreased in the epithelium and specifically increased in OCP stroma, as compared to controls (Fig 3A and 3B ; p < .05). Indeed, confocal analysis showed higher cytoplasmic and perinuclear NGF immunoreactivity in outgrew OCP-FBs, supporting those data observed in OCP stroma (see arrows; Fig 3C) . In addition, the conditioned media from OCP-FBs showed higher NGF levels than those of control counterparts (420.00±90.00 vs. 220.00±64.00 pg/mL; p < .05), as detected by NGF ELISA. In line, NGFmRNA was increased in these OCP-FBs, as compared to their control FBs (+5.00±1.30 expression ratio; p < .05). No significant difference was quantified between early and advanced specimens. Confocal analysis showed a high p75 NTR expression associated with a weak trkA NGFR expression in OCP-FBs (Fig 4B) . By contrary, control FBs showed a huge trkA NGFR expression with respect to p75 NTR slightly expressed (Fig 4A) . To support, the related FCM analysis for trkA NGFR and p75 NTR are provided in Fig 4C and 4D respectively.
αSMA and p75
NTR co-expression in OCP-derived activated FBs
The higher αSMA and p75 NTR and the lower trkA NGFR protein expressions in OCP-FBs were also detected by WB analysis, as compared to control FBs (Fig 5A; p<0.05 ). As shown in Fig  5B, αSMA protein co-localized with p75 NTR but not with trkA NGFR , as detected by confocal analysis. This would suggest the existence of a specific trkA NGFR /p75 NTR expression ratio during the progress of fibrosis. Particularly, basal histology showed a strong infiltration of inflammatory cells (arrows pointing to plasmacells in Fig 1C) , the presence of connective tissue homogenization (asterisk in 1D and 1F) in the underlying stroma ( §) and a significant decrease (absence) of goblet cells in the epithelium of advanced OCP sections (see arrowheads pointing residual goblet cells in early OCP) (Fig 1C and 1E) . Activated fibroblast were also visible in early OCP (Fig 1C) in NGF exposed early OCP-FBs is shown (Fig 6) .
NGF modulation of OCP-activated FBs derived TGFβ1 and IL4 cytokines
Last, changes in TGFβ1 and IL4 profibrogenic factor release were also detected in the conditioned media from baseline and NGF treated OCP-FBs. TGFβ1 and IL4 levels in the conditioned media from early OCP-FBs were respectively 8-times (101.00±30.00 vs. 12.00±2.10 pg/ mL TGFβ1, p < .05) and 6-times (308.00±7.00 vs. 55.00±40.00 pg/mL IL4; p < .001) higher as compared to control counterparts. Conditioned media from advanced OCP-FBs did not show difference in both TGFβ1 and IL4 levels, as compared to controls. Upon 10ng/mL NGF exposure, IL4 protein decreased in the conditioned media from early (26.00±10.00 vs. 101.00±30.00 pg/mL IL4; p < .05) and advanced (1.80±0.30 vs. 23.00±4.80 pg/mL IL4; p < .05) OCP-FBs. By contrary, TGFβ1 levels decreased only in the conditioned media from early OCP-FBs (63.00 ±40.00 vs. 308.00±7.00 pg/mL TGFβ1; p < .05).
Discussion
Increasing data indicate that the chronic inflammatory process occurring in OCP conjunctiva leads to FB activation and survival, with overt collagen deposition and excessive matrix deposition [3] . As a product of different structural/immune cells and FBs/myoFBs, both cytokines and growth factors actively contribute to subepithelial fibrosis and conjunctival scarring [25] . To date, different proinflammatory and profibrogenic factors have been investigated by different groups, which have focused their attention especially on receptor signalling [26] . While in a previous study we have described the trkA NGFR and NGF expression respectively in OCP conjunctivas and tears, herein we hypothesize a possible NGF role in the modulation of cultured OCP-FBs [8, 9] . First of all, αSMA expression was detected in OCP conjunctiva and confirmed in primary cultures of FBs obtained from OCP explants. αSMA (α-Smooth Muscle Actin) represents the most reliable phenotypic marker for the majority of fibrotic states. Our findings indicate the presence of activated FBs inside inflamed/fibrotic OCP conjunctiva [7, 27, 28] . If these activated FBs are αSMA-expressing myofibroblast (myoFBs) remains to be clarified since in previous studies the possible differentiation of OCP-FBs into myoFBs was not reported [29] . An increase in the stroma and a significant decrease in the epithelium were detected for NGF in OCP conjunctival biopsies (n = 7), as compared to control ones. To the best of our knowledge, this data has not been previously described and it is supported by our recent findings showing an increased NGF content in OCP tear fluids [8, 9] . The observation of NGFexpressing OCP-FBs might suggest that the NGF increase in OCP stroma as well as the increased NGF levels in OCP tears might be partially due to local activated-FBs. On the other side, the decreased NGF immunoreactivity in OCP epithelium is actually missing of explanation and not investigated/discussed in this study.
As product of stromal inflammation, it is reasonable to hypothesize that NGF might contribute to tissue remodeling by influencing the FB phenotype, as observed in previous studies conducted on other cell types [14, 17, 18, 20] . With respect to the activated FB phenotype, NGF effects might cover either cell survival and/or soluble mediator release [14, 17] . According to literature, NGF activity is driven by trkA NGFR and p75 NTR receptors, which mediate NGF signal alone or in cooperation [30] [31] [32] [33] [34] [35] [33, [39] [40] [41] . As described, fibrotic tissues appear characterized by low trkA NGFR and high p75 NTR expression [17, 18, 20] . In this study, a higher trkA NGFR /p75 NTR ratio (the outcome of a trkA NGFR over-expression) was observed in early OCP-FBs while lower trkA NGFR /p75 NTR ratio (the outcome of an increased p75 NTR expression) was detected in advanced OCP-FBs, according to the clinical and histological features (infiltrates and remodelling features) [2, 22, 42] . To support our findings, the lower trkA NGFR /p75 NTR ratio expression in advanced OCP-FBs (the outcome of an increased p75 NTR expression) has been also reported in other fibrotic conditions, either in vitro/ex vivo [7, 17, 18, 28, 43] . A down-regulation of both αSMA and p75 NTR expression was observed in NGF-exposed early OCP-FBs, while no effect was detected in NGF-exposed advanced counterpart. The observation that NGF modulated trkA NGFR /p75 NTR ratio expression preferentially in early OCP-FBs would suggest that a potential control of activated FBs might be possible in early OCP showing a mild-moderate clinical facet, opening to potential NGF therapeutic applications. As shown, activated FBs disappear alongside "proper repair process" while αSMA-expressing activated FBs survive in pathological remodelling [7, 28] . This process might be highly regulated by growth factors and cytokines, including NGF, all known to be increased in OCP tissues and tears [5, 6, 8, 9] . Therefore, a possible cross-talk between NGF and other profibrogenic factors cannot be excluded. In line, TGFβ1 and IL4 were extensively investigated in fibrosis and are widely reported to contribute selectively to tissue remodelling and overt fibrosis in different disorders via an extensive sustaining of myoFBs [2, 6, 28, 44] . Therefore, we wonder whether NGF might influence TGFβ1 and IL4 release from sub-cultures of OCP-FBs. The biochemical analysis highlighted a significant decrease of TGFβ1 and IL4 in the conditioned media from NGF-exposed early OCP-FBs, while only a decrease of IL4 was monitored in advanced counterparts. This selective effect holds up the potential NGF involvement in OCP remodelling, through a modulation of inflammatory/fibrogenic soluble factors, at least in early stage of disease. Overall, OCP is a chronic inflammatory disease that slowly evolves in severe conjunctival scarring and visual impairments [1, 2, 45] . Most of the current OCP therapies target the suppression of inflammation, as counteracting the recurrent inflammation represents the main way to reduce progressive remodelling [46] [47] [48] . The findings of this in vitro study suggest a possible NGF effect on early OCP-FBs having a low trkA NGFR /p75 NTR ratio, highlighting the possible NGF effect in the modulation of FB activity during the early stages of disease. Since the topical NGF application has been suggested as a therapeutic tool in some ocular surface disorders [11, 49] , these findings encourage further studies to understand the underlying NGF mechanism in OCP conjunctiva in order to develop alternative strategies to counteract fibrosis.
